tiprankstipranks
Trending News
More News >
Kato (Hong Kong) Holdings Ltd. (HK:2189)
:2189
Hong Kong Market
Advertisement

Kato (Hong Kong) Holdings Ltd. (2189) AI Stock Analysis

Compare
1 Followers

Top Page

HK

Kato (Hong Kong) Holdings Ltd.

(2189)

Rating:64Neutral
Price Target:
Kato (Hong Kong) Holdings Ltd. displays strong financial fundamentals with robust profitability and solid cash flow management, contributing positively to its score. However, the technical analysis suggests bearish momentum, acting as a drag on the overall score. The valuation appears favorable with a low P/E ratio and high dividend yield, enhancing the attractiveness of the stock. Despite the revenue decline, the company's financial health supports its resilience.

Kato (Hong Kong) Holdings Ltd. (2189) vs. iShares MSCI Hong Kong ETF (EWH)

Kato (Hong Kong) Holdings Ltd. Business Overview & Revenue Model

Company DescriptionKato (Hong Kong) Holdings Limited, an investment holding company, engages in the provision of residential and day care services for the elderly in Hong Kong. The company provides a range of residential care services for the elderly, including accommodation, professional nursing and care-taking, nutritional management, medical, physiotherapy and occupational therapy, psychological and social care, individual care, and recreational services; and sells healthcare and medical goods, as well as offers add-on healthcare services to its residents. It also operates home care support services; and invests in properties, as well as provides properties management services. As of March 31, 2022, it operated eight care and attention homes for the elderly with 1,129 residential care places across four districts in Hong Kong under the Fai To, Kato, Happy Luck Home, Tsuen Wan Centre, and Pine Villa brand names. The company was founded in 1991 and is based in Tuen Mun, Hong Kong. Kato (Hong Kong) Holdings Limited is a subsidiary of Sheung Fung Limited.
How the Company Makes MoneyKato (Hong Kong) Holdings Ltd. generates revenue primarily through the operation of its residential care homes for the elderly. The company charges fees for various services provided to residents, including room and board, personal care, and specialized nursing services. In addition to basic care services, Kato Holdings may also offer ancillary services such as physiotherapy, recreational activities, and medical consultations, which contribute additional revenue streams. The company's earnings are significantly influenced by occupancy rates in its facilities, the quality and range of services offered, and its ability to maintain a trusted reputation in the community. Kato Holdings may also benefit from partnerships with healthcare providers and government agencies supporting elderly care initiatives.

Kato (Hong Kong) Holdings Ltd. Financial Statement Overview

Summary
Kato (Hong Kong) Holdings Ltd. demonstrates strong profitability and efficient cash flow management. While revenue has decreased, profit margins and cash flow stability provide a solid financial position. The balance sheet remains healthy, with a balanced debt-to-equity ratio and high return on equity. Despite the current revenue challenges, the company is positioned well with its strong financial fundamentals.
Income Statement
62
Positive
The company has shown a decrease in revenue from HK$408.3M to HK$271.3M, reflecting a negative revenue growth rate. However, gross and net profit margins remain robust at 49.8% and 23.7%, respectively, indicating efficient cost management. EBIT and EBITDA margins are also strong at 43.1% and 49.2%, demonstrating operational efficiency. Despite the revenue decline, profitability metrics are solid.
Balance Sheet
68
Positive
The debt-to-equity ratio stands at 0.88, indicating a moderate level of leverage, while the equity ratio at 50.3% suggests a stable capital structure. Return on Equity (ROE) is strong at 14.8%, reflecting efficient use of equity capital. Overall, the balance sheet is healthy, with manageable debt levels and solid equity backing.
Cash Flow
70
Positive
The company has maintained a positive operating cash flow to net income ratio of 2.06, indicating good cash generation relative to net income. Free cash flow growth is positive at 4.2%, and the free cash flow to net income ratio is 1.68, highlighting effective cash flow management. Cash flow stability supports operational and financial flexibility.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue284.15M271.33M408.30M320.34M256.53M196.10M
Gross Profit143.09M135.21M185.43M143.75M123.15M85.16M
EBITDA75.11M133.61M206.90M161.67M131.88M90.90M
Net Income69.92M64.19M126.15M98.94M79.87M47.87M
Balance Sheet
Total Assets839.00M863.30M699.30M621.62M602.60M348.87M
Cash, Cash Equivalents and Short-Term Investments52.53M68.71M78.53M58.24M109.12M183.74M
Total Debt357.84M384.30M270.03M294.79M342.05M138.26M
Total Liabilities398.03M428.77M326.36M329.41M369.44M156.20M
Stockholders Equity440.89M434.29M372.63M291.53M232.63M192.67M
Cash Flow
Free Cash Flow128.06M108.10M103.78M42.00M111.80M64.15M
Operating Cash Flow103.75M132.42M159.91M118.98M117.95M74.26M
Investing Cash Flow-125.31M-236.10M-55.89M-75.39M-105.33M-150.61M
Financing Cash Flow29.94M69.67M-84.02M-93.67M52.25M71.50M

Kato (Hong Kong) Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.45
Price Trends
50DMA
0.46
Negative
100DMA
0.46
Negative
200DMA
0.48
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
37.74
Neutral
STOCH
16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2189, the sentiment is Negative. The current price of 0.45 is below the 20-day moving average (MA) of 0.45, below the 50-day MA of 0.46, and below the 200-day MA of 0.48, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 37.74 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2189.

Kato (Hong Kong) Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$368.44M8.575.95%12.17%0.81%27.55%
64
Neutral
HK$450.00M20.555.02%11.11%-15.22%-21.37%
64
Neutral
HK$598.57M36.021.07%8.94%-1.20%-87.51%
59
Neutral
HK$405.12M7.818.82%2.66%-10.82%-44.11%
58
Neutral
HK$318.82M15.192.73%3.33%-0.69%
52
Neutral
$7.52B0.21-63.76%2.30%16.15%0.89%
48
Neutral
HK$718.61M-10.78%-0.95%-128.35%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2189
Kato (Hong Kong) Holdings Ltd.
0.44
-0.07
-13.73%
HK:1419
Human Health Holdings Ltd.
0.83
-0.20
-19.42%
HK:1518
New Century Healthcare Holding Co. Ltd.
0.82
0.07
9.33%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.79
-0.59
-24.79%
HK:3869
Hospital Corporation of China Ltd
5.20
-1.10
-17.46%
HK:0722
UMP Healthcare Holdings Limited
0.46
0.02
4.55%

Kato (Hong Kong) Holdings Ltd. Corporate Events

Kato Holdings Secures Unanimous Approval for Tenancy Renewals
Feb 19, 2025

Kato (Hong Kong) Holdings Limited announced that all proposed resolutions were unanimously approved by independent shareholders during an Extraordinary General Meeting held on February 19, 2025. The resolutions pertained to the renewal of various tenancy agreements related to the company’s operations. This approval ensures the continuity of Kato’s facilities and is a crucial step for maintaining its operational stability and strategic positioning in the market.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 22, 2025